Catatan efek · kuartal yang diarsipkan
EOLS
Evolus, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15Pemegang yang dilacak
0Δ pemegang
14.12MSaham yang dipegang
$130.04MNilai yang dilaporkan
+1Posisi baru
−1Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -3.9% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 63 | +6 | 23.25M | $161.16M | +10 | −4 |
| Q1 2026 | 59 | -7 | 18.93M | $77.97M | +3 | −10 |
| Q4 2025 | 66 | -1 | 24.04M | $159.85M | — | −1 |
| Q3 2025 | 17 | -1 | 17.27M | $106.03M | — | −1 |
| Q2 2025 | 15 | 0 | 14.12M | $130.04M | +1 | −1 |
| Q1 2025 | 12 | +2 | 7.19M | $86.49M | +2 | — |
| Q4 2024 | 10 | -1 | 6.42M | $70.90M | — | −1 |
| Q3 2024 | 10 | 0 | 4.64M | $75.21M | +1 | −1 |
| Q2 2024 | 10 | — | 4.38M | $47.51M | — | — |
Siapa yang memegangnya · Q2 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasif) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasif) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasif) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasif) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasif) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 1.48M | +6.6% | $13.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (pasif) | 1.41M | +1.7% | $12.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasif) | 1.23M | -2.4% | $11.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (pasif) | 1.23M | -2.4% | $11.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 957.74K | +9.2% | $8.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 957.74K | +9.2% | $8.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 581.86K | +135.1% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 581.86K | +135.1% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 341.40K | +318.4% | $3.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Adage Capital Partners ✦ | 128.40K | -73.6% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 123.86K | -35.4% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Marshall Wace ✦ | 67.85K | Baru | $624,860 | 0.0% | New | 1 | SEC ↗ |
| 37 | Marshall Wace ✦ | 67.85K | Baru | $624,860 | 0.0% | New | 1 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 56.32K | +3.1% | $519,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 2.42K | — | $22,246 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 2.42K | — | $22,246 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $624,860 | 0.0% |
| Marshall Wace | $624,860 | 0.0% |
Telah keluar
| Soros Fund Management | $11.98M | adalah 0.3% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 146 pemegang, 45.63M saham, $187.01M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q2 2025 ·
Metodologi ·
Dapatkan ini melalui API